<p>(<b>A</b>) Glucose tolerance test and (<b>B</b>) insulin tolerance test carried out in HFD- or chow-fed mice supplemented or not with leucine in drinking water (n = 10-11 per group). (<b>C</b>) Fasting plasma glucose, (<b>D</b>) fasting plasma insulin and (<b>E</b>) HOMA index measured in mice on HFD supplemented or not with leucine in drinking water (n = 10-11 per group). <sup>*</sup><i>p</i><0.05 vs. HFD-water group; <sup>#</sup><i>p</i><0.05 vs. chow-fed groups.</p
<p>(<b>a</b> and <b>d</b>) oral glucose tolerance; (<b>b</b> and <b>e</b>) plasma insulin during the...
<p><i>A</i>: Leptin sensitivity, as measured by the percentage change in food intake after leptin ad...
<p>A) Fasted glucose of WT (n = 6) and T1R3 KO (n = 9) mice. B) IP GTT in WT (n = 6) and T1R3 KO (n ...
<p>(A) G6Pase activity in the jejunum of HFD-fed mice supplemented or not with leucine in drinking w...
<p>(<b>A</b>) Fat mass, expressed as % of body weight, in HFD-fed mice supplemented or not with leuc...
<p>(A) Body weight curve and (B) mean daily food intake of mice exposed to HFD or chow and supplemen...
<p>(<b>A</b>) Glucose tolerance and (<b>B</b>) insulin tolerance tests carried out in obese mice res...
<div><p>Background</p><p>Leucine supplementation might have therapeutic potential in preventing diet...
Background: Leucine supplementation might have therapeutic potential in preventing diet-induced obes...
<p>Serum leptin <b>(A)</b> and insulin <b>(B)</b> levels measured after 8 weeks of HFD treatment in ...
<p>(<b>A</b>) Plasma amino acids and (<b>B</b>) acylcarnitines deriving from leucine metabolism meas...
<p> (<b>A</b>) Six hour fasting blood glucose was measured from a tail snip of each mouse using a ha...
<p>After the treatment period, insulin-treated HFD mice were significantly heavier, when compared to...
<p>(A) ITT, following a 6 hr fast blood glucose levels were assessed at the indicated times followin...
<p>(<b>A</b>) Fasting blood glucose was measured once a week after an 8-hour fast. (<b>B</b>) Plasma...
<p>(<b>a</b> and <b>d</b>) oral glucose tolerance; (<b>b</b> and <b>e</b>) plasma insulin during the...
<p><i>A</i>: Leptin sensitivity, as measured by the percentage change in food intake after leptin ad...
<p>A) Fasted glucose of WT (n = 6) and T1R3 KO (n = 9) mice. B) IP GTT in WT (n = 6) and T1R3 KO (n ...
<p>(A) G6Pase activity in the jejunum of HFD-fed mice supplemented or not with leucine in drinking w...
<p>(<b>A</b>) Fat mass, expressed as % of body weight, in HFD-fed mice supplemented or not with leuc...
<p>(A) Body weight curve and (B) mean daily food intake of mice exposed to HFD or chow and supplemen...
<p>(<b>A</b>) Glucose tolerance and (<b>B</b>) insulin tolerance tests carried out in obese mice res...
<div><p>Background</p><p>Leucine supplementation might have therapeutic potential in preventing diet...
Background: Leucine supplementation might have therapeutic potential in preventing diet-induced obes...
<p>Serum leptin <b>(A)</b> and insulin <b>(B)</b> levels measured after 8 weeks of HFD treatment in ...
<p>(<b>A</b>) Plasma amino acids and (<b>B</b>) acylcarnitines deriving from leucine metabolism meas...
<p> (<b>A</b>) Six hour fasting blood glucose was measured from a tail snip of each mouse using a ha...
<p>After the treatment period, insulin-treated HFD mice were significantly heavier, when compared to...
<p>(A) ITT, following a 6 hr fast blood glucose levels were assessed at the indicated times followin...
<p>(<b>A</b>) Fasting blood glucose was measured once a week after an 8-hour fast. (<b>B</b>) Plasma...
<p>(<b>a</b> and <b>d</b>) oral glucose tolerance; (<b>b</b> and <b>e</b>) plasma insulin during the...
<p><i>A</i>: Leptin sensitivity, as measured by the percentage change in food intake after leptin ad...
<p>A) Fasted glucose of WT (n = 6) and T1R3 KO (n = 9) mice. B) IP GTT in WT (n = 6) and T1R3 KO (n ...